Survival analysis found that elevated CDCA2 expression was related to a poor prognosis (OS, DSS, PFI) in ACC, BLCA, ESCC, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, and SARC (Fig 5, S2 and S3 Figs). This evidence concerns the gene CDCA2 and bladder transitional cell carcinoma.